ethereal 发表于 2025-3-25 04:41:06

http://reply.papertrans.cn/25/2426/242523/242523_21.png

角斗士 发表于 2025-3-25 11:05:44

https://doi.org/10.1007/978-3-642-47430-9responsiveness. Here, PDAI, ABSIS, and PVAS are presented and compared based on their measurement properties including reliability, feasibility, and correlation with anti-desmoglein levels using one large prospective study (n = 100) comparing all three measures. Additionally, a review of additional

hermitage 发表于 2025-3-25 14:10:18

http://reply.papertrans.cn/25/2426/242523/242523_23.png

Condense 发表于 2025-3-25 19:32:43

http://reply.papertrans.cn/25/2426/242523/242523_24.png

轻弹 发表于 2025-3-25 20:42:32

http://reply.papertrans.cn/25/2426/242523/242523_25.png

开始从未 发表于 2025-3-26 00:40:08

http://reply.papertrans.cn/25/2426/242523/242523_26.png

PRO 发表于 2025-3-26 07:02:27

http://reply.papertrans.cn/25/2426/242523/242523_27.png

TSH582 发表于 2025-3-26 11:02:30

Yosuke Nagaoka,Hidetoshi Fukuyama erythema or phyma or two of the major criteria, which include flushing, papules/pustules, telangiectasia, and ocular manifestations. Assessment of facial erythema is of importance given its prevalence as the most common diagnostic feature of rosacea. Both physician-reported and patient-reported mea

tenuous 发表于 2025-3-26 16:08:19

http://reply.papertrans.cn/25/2426/242523/242523_29.png

修改 发表于 2025-3-26 19:38:39

http://reply.papertrans.cn/25/2426/242523/242523_30.png
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Cutaneous Biometrics; Howard Maibach,Nily Osman Book 2024Latest edition Springer Nature Switzerland AG 2024 clinical relevance percutaneou